Editas Medicine, Inc(NASDAQ:EDIT) 
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. ...
Website: http://www.editasmedicine.com
Founded: 2013
Full Time Employees: 208
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.10
H 1.15
L 1.02
C 1.03
V 3,114,549
10EMA 1.03
20EMA 1.03
60EMA 1.03
120EMA 1.03
250EMA 1.03